PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome
ContributorsPasset, Marie; Boissel, Nicolas; Sigaux, François; Saillard, Colombe; Bargetzi, Mario; Bah, Ibrahima Fatoumata; Thomas, Xavier; Graux, Carlos; Chalandon, Yves; Leguay, Thibaut; Lengliné, Etienne; Konopacki, Johanna; Quentin, Samuel; Delabesse, Eric; Lafage-Pochitaloff, Marina; Pastoret, Cédric; Grardel, Nathalie; Asnafi, Vahid; Lhéritier, Véronique; Soulier, Jean; Dombret, Hervé; Clappier, Emmanuelle; Group for Research on Adult ALL (GRAALL)
Published inBlood, vol. 133, no. 3, p. 280-284
Publication date2019
Keywords
- Adult
- Cohort Studies
- Follow-Up Studies
- Humans
- Mutation
- Neoplasm Recurrence
- Local/genetics/pathology/therapy
- PAX5 Transcription Factor/genetics
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/classification/genetics/pathology/therapy
- Prognosis
- Stem Cell Transplantation
- Survival Rate
- Transplantation
- Homologous
Affiliation entities
Citation (ISO format)
PASSET, Marie et al. PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome. In: Blood, 2019, vol. 133, n° 3, p. 280–284. doi: 10.1182/blood-2018-10-882142
Main files (1)
Article (Published version)
Secondary files (1)
Supplemental data
Identifiers
- PID : unige:135517
- DOI : 10.1182/blood-2018-10-882142
- PMID : 30510083
Journal ISSN0006-4971
